According to the Huacheng Import and Export Data Observation Report, five departments including Tianjin Food and Drug Administration jointly issued the Tianjin Pilot Plan for the Import of Biomedical R&D Articles, which piloted the implementation of the white list (hereinafter referred to as the "white list") system for the import of R&D articles by biomedical enterprises (R&D institutions) in Tianjin.
According to Huacheng Import and Export Data Observation, the "white list" system, based on the principle of "optimizing innovation, efficient service, convenient customs clearance, and controllable risk", allows biomedical enterprises (R&D institutions) to go through import declaration and clearance procedures at Tianjin Customs on behalf of the Imported Drugs Customs Clearance Form with the "white list" identification document when handling the import of R&D articles. The "white list" consists of two parts: pilot enterprises and pilot articles. The pilot enterprises should have the business scale and R&D capabilities that match the pilot R&D work, ensure the scientific, reasonable and safe use of imported articles in the R&D process, and have the ability to trace the whole process of using articles. Huacheng Import and Export Data Observation Report.
In order to promote the smooth implementation of the "white list" system, Tianjin has established a joint promotion mechanism of the "white list" system led by the Municipal Food and Drug Administration and jointly participated by the Municipal Science and Technology Bureau, the Municipal Bureau of Commerce, Tianjin Customs and the Free Trade Zone Management Committee. The Joint Promotion Mechanism Office is located in the Municipal Drug Administration, and Huacheng's import and export data observation report.
The "white list" system, driven by innovation, ensures the smooth import of R&D materials of enterprises, effectively solves the bottleneck problem that plagues the development of the industry, and brings more convenience to pharmaceutical R&D innovation. At present, many biomedical enterprises in Tianjin are actively preparing to apply, and Huacheng's import and export data observation report.